Quick Answer Adaptive Biotechnologies Corp reported Diluted EPS of $0.39 per share (loss) for fiscal year 2025. Adaptive Biotechnologies Corp Diluted EPS — Annual History Fiscal Year Diluted EPS YoY Change 2025 -$0.39 +63.9% 2024 -$1.08 +30.8% 2023 -$1.56 -11.4% 2022 -$1.40 +5.4% 2021 -$1.48 -33.3% 2020 -$1.11 — Quarterly Diluted EPS Quarter Ending Diluted … Read more
Quick Answer Adaptive Biotechnologies Corp reported Net Income of -$59.50 million for fiscal year 2025. Adaptive Biotechnologies Corp Net Income — Annual History Fiscal Year Net Income YoY Change 2025 -$59.50M +62.7% 2024 -$159.49M +29.2% 2023 -$225.25M -12.5% 2022 -$200.19M +3.4% 2021 -$207.28M -41.8% 2020 -$146.23M -113.1% 2019 -$68.61M -47.7% 2018 -$46.45M -8.4% 2017 -$42.83M … Read more
Quick Answer Adaptive Biotechnologies Corp reported Revenue (ASC 606) of $276.98 million for fiscal year 2025. Adaptive Biotechnologies Corp Revenue (ASC 606) — Annual History Fiscal Year Revenue (ASC 606) YoY Change 2025 $276.98M +54.8% 2024 $178.96M +5.1% 2023 $170.28M -8.1% 2022 $185.31M +20.1% 2021 $154.34M +56.9% 2020 $98.38M +15.6% 2019 $85.07M +52.8% 2018 $55.66M … Read more
Quick Answer Adaptive Biotechnologies Corp reported Total Revenue of $276.98 million for fiscal year 2025. Adaptive Biotechnologies Corp Total Revenue — Annual History Fiscal Year Total Revenue YoY Change 2025 $276.98M +54.8% 2024 $178.96M +5.1% 2023 $170.28M -8.1% 2022 $185.31M +20.1% 2021 $154.34M +56.9% 2020 $98.38M +15.6% 2019 $85.07M +52.8% 2018 $55.66M +44.8% 2017 $38.45M … Read more
Quick Answer Adaptive Biotechnologies Corp reported Total Revenue of $276.98 million for fiscal year 2025. Adaptive Biotechnologies Corp — Key Financials by Year Metric 2025 2024 2023 2022 2021 2020 Total Revenue $276.98M+54.8% $178.96M+5.1% $170.28M-8.1% $185.31M+20.1% $154.34M+56.9% $98.38M+15.6% Revenue (ASC 606) $276.98M+54.8% $178.96M+5.1% $170.28M-8.1% $185.31M+20.1% $154.34M+56.9% $98.38M+15.6% Net Income -$59.50M+62.7% -$159.49M+29.2% -$225.25M-12.5% -$200.19M+3.4% -$207.28M-41.8% -$146.23M-113.1% … Read more
Quick Answer AUTOMATIC DATA PROCESSING INC reported Shares Outstanding of 405.30 million shares for fiscal year 2025. AUTOMATIC DATA PROCESSING INC Shares Outstanding — Annual History Fiscal Year Shares Outstanding YoY Change 2025 405.30M -0.7% 2024 408.10M -1.0% 2023 412.10M -1.0% 2022 416.10M -1.8% 2021 423.70M -1.4% 2020 429.90M -1.0% 2019 434.20M -1.0% 2018 438.80M … Read more
Quick Answer AUTOMATIC DATA PROCESSING INC reported Stockholders Equity of $6.19 billion for fiscal year 2025. AUTOMATIC DATA PROCESSING INC Stockholders Equity — Annual History Fiscal Year Stockholders Equity YoY Change 2025 $6.19B +36.1% 2024 $4.55B +29.6% 2023 $3.51B +8.8% 2022 $3.23B -43.1% 2021 $5.67B -1.4% 2020 $5.75B +6.5% 2019 $5.40B +14.0% 2018 $4.74B +19.1% … Read more
Quick Answer AUTOMATIC DATA PROCESSING INC reported R&D Expense of $988.60 million for fiscal year 2025. AUTOMATIC DATA PROCESSING INC R&D Expense — Annual History Fiscal Year R&D Expense YoY Change 2025 $988.60M +3.4% 2024 $955.70M +13.1% 2023 $844.80M +5.8% 2022 $798.60M — Quarterly R&D Expense Quarter Ending R&D Expense YoY QoQ December 31, 2025 … Read more
Quick Answer AUTOMATIC DATA PROCESSING INC reported Long-Term Debt of $3.97 billion for fiscal year 2025. AUTOMATIC DATA PROCESSING INC Long-Term Debt — Annual History Fiscal Year Long-Term Debt YoY Change 2025 $3.97B +32.9% 2024 $2.99B +0.1% 2023 $2.99B +0.1% 2022 $2.99B +0.1% 2021 $2.98B +197.7% 2020 $1.00B -49.9% 2019 $2.00B -0.0% 2018 $2.00B +0.0% … Read more
Quick Answer AUTOMATIC DATA PROCESSING INC reported Cash and Equivalents of $3.35 billion for fiscal year 2025. AUTOMATIC DATA PROCESSING INC Cash and Equivalents — Annual History Fiscal Year Cash and Equivalents YoY Change 2025 $3.35B +14.9% 2024 $2.91B +39.8% 2023 $2.08B +45.1% 2022 $1.44B -44.2% 2021 $2.58B +34.9% 2020 $1.91B -2.1% 2019 $1.95B -10.2% … Read more